Literature DB >> 23566545

Right ventricular stroke work index as a negative predictor of mortality and initial hospital stay after lung transplantation.

Hilary F Armstrong1, P Christian Schulze, Tomoko S Kato, Matthew Bacchetta, Wilawan Thirapatarapong, Matthew N Bartels.   

Abstract

BACKGROUND: Studies have shown that patients with poor pre-lung transplant (LTx) right ventricular (RV) function have prolonged post-operative ventilation time and intensive care stay as well as a higher risk of in-hospital death. RV stroke work index (RVSWI) calculates RV workload and contractility. We hypothesized that patients with higher RV workload capacity, indicated by higher RVSWI, would have better outcomes after LTx.
METHODS: A retrospective record review was performed on all LTx patients between 2005 and 2011 who had right heart catheterizations (RHC) 1-year before LTx. In addition, results for echocardiograms and cardiopulmonary exercise testing within 1-year of RHCs were gathered.
RESULTS: Mean RVSWI was 9.36 ± 3.59 for 115 patients. There was a significant relation between mean pulmonary artery pressure (mPAP), RVSWI, RV end-diastolic diameter (RVEDd), left atrial dimension (LAD), peak and resting pressure of end-tidal carbon dioxide, minute ventilation /volume of carbon dioxide production, and 1-year mortality after LTx. Contrary to our hypothesis, those who survived had lower RVSWI than those who died within 1 year (8.99 ± 3.38 vs 11.6 ± 4.1, p = 0.026). Hospital length of stay significantly correlated with mPAP, RVSWI, left ventricular ejection fraction, percentage of fractional shortening, RVEDd, RV fractional area change, LAD, and RV wall thickness in diastole. Intensive care length of stay also significantly correlated with these variables and with body mass index. RVSWI was significantly different between groups of different RV function, indicating that increased RVSWI is associated with impairment of RV structure and function in patients undergoing LTx evaluation.
CONCLUSIONS: This study demonstrates an association between 1-year mortality, initial hospital and intensive care length of stay, and pre-LTx RVSWI. Increased mPAP is a known risk for outcomes in LTx patients. Our findings support this fact and also show increased mortality with elevation of RVSWI, demonstrating the value of RV function in the assessment of risk for pre-LTx patients.
Copyright © 2013 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23566545      PMCID: PMC4945758          DOI: 10.1016/j.healun.2013.03.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

1.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

2.  Impact of preoperative right-ventricular function and platelet transfusion on outcome after lung transplantation.

Authors:  Marco P Zalunardo; Caroline Thalmann; Burkhardt Seifert; Jaya D'Cunja; Walter Weder; Annette Boehler; Donat R Spahn
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-08       Impact factor: 4.191

3.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

Authors:  Jonathan B Orens; Marc Estenne; Selim Arcasoy; John V Conte; Paul Corris; Jim J Egan; Thomas Egan; Shaf Keshavjee; Christiane Knoop; Robert Kotloff; Fernando J Martinez; Steven Nathan; Scott Palmer; Alec Patterson; Lianne Singer; Gregory Snell; Sean Studer; J L Vachiery; Allan R Glanville
Journal:  J Heart Lung Transplant       Date:  2006-07       Impact factor: 10.247

Review 4.  Diagnosis and assessment of pulmonary arterial hypertension.

Authors:  David B Badesch; Hunter C Champion; Miguel Angel Gomez Sanchez; Marius M Hoeper; James E Loyd; Alessandra Manes; Michael McGoon; Robert Naeije; Horst Olschewski; Ronald J Oudiz; Adam Torbicki
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.

Authors:  J D Hosenpud; L E Bennett; B M Keck; E B Edwards; R J Novick
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

6.  Effect of pulmonary vasoconstriction on balance between alveolar ventilation and perfusion.

Authors:  F Haas; E H Bergofsky
Journal:  J Appl Physiol       Date:  1968-04       Impact factor: 3.531

7.  Impact of previous cardiovascular disease on the outcome of lung transplantation.

Authors:  Laurent Plantier; Neji Skhiri; Giuseppina Biondi; Gilles Jebrak; Dominique Himbert; Yves Castier; Guy Lesèche; Hervé Mal; Gabriel Thabut; Michel Fournier
Journal:  J Heart Lung Transplant       Date:  2010-07-01       Impact factor: 10.247

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.

Authors:  Yoshie Ochiai; Patrick M McCarthy; Nicholas G Smedira; Michael K Banbury; Jose L Navia; Jingyuan Feng; Amy P Hsu; Michael L Yeager; Tiffany Buda; Katherine J Hoercher; Michael W Howard; Masami Takagaki; Kazuyoshi Doi; Kiyotaka Fukamachi
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

10.  Pulmonary hypertension is associated with reduced patient survival after kidney transplantation.

Authors:  Naim Issa; Michael J Krowka; Matthew D Griffin; LaTonya J Hickson; Mark D Stegall; Fernando G Cosio
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

View more
  13 in total

1.  Starting a lung transplant program: a roadmap for long-term excellence.

Authors:  Julia Klesney-Tait; Michael Eberlein; Lois Geist; John Keech; Joseph Zabner; Peter J Gruber; Mark D Iannettoni; Kalpaj Parekh
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

Review 2.  Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension.

Authors:  Rupa K Patil; Parag Goyal; Rajesh V Swaminathan; Luke K Kim; Dmitriy N Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

3.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

4.  High Right Ventricular Stroke Work Index Is Associated with Worse Kidney Function in Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Napatt Kanjanahattakij; Natee Sirinvaravong; Francisco Aguilar; Akanksha Agrawal; Parasuram Krishnamoorthy; Shuchita Gupta
Journal:  Cardiorenal Med       Date:  2018-02-28       Impact factor: 2.041

Review 5.  A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy.

Authors:  Ersilia M DeFilippis; Marco Guazzi; Paolo C Colombo; Melana Yuzefpolskaya
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

6.  Prognostic value of pre-transplant mean pulmonary arterial pressure in lung transplant recipients: a single-institution experience.

Authors:  Chi Young Kim; Ji Eun Park; Ah Young Leem; Joo Han Song; Song Yee Kim; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Joon Chang; Jin Gu Lee; Hyo Chae Paik; Moo Suk Park
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension.

Authors:  Katharine R Clapham; Kristin B Highland; Youlan Rao; Wassim H Fares
Journal:  Front Cardiovasc Med       Date:  2020-04-30

8.  Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.

Authors:  Hilmi Alnsasra; Rabea Asleh; Sarah D Schettle; Naveen L Pereira; Robert P Frantz; Brooks S Edwards; Alfredo L Clavell; Simon Maltais; Richard C Daly; John M Stulak; Andrew N Rosenbaum; Atta Behfar; Sudhir S Kushwaha
Journal:  J Am Heart Assoc       Date:  2019-08-14       Impact factor: 5.501

9.  Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart.

Authors:  Andreas J Rieth; Manuel J Richter; Khodr Tello; Henning Gall; Hossein A Ghofrani; Stefan Guth; Christoph B Wiedenroth; Werner Seeger; Steffen D Kriechbaum; Veselin Mitrovic; P Christian Schulze; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2021-06-10       Impact factor: 5.460

10.  Right ventricular functional analysis utilizing first pass radionuclide angiography for pre-operative ventricular assist device planning: a multi-modality comparison.

Authors:  Ryan Avery; Kevin Day; Clinton Jokerst; Toshinobu Kazui; Elizabeth Krupinski; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-10-10       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.